Gx Inbeneo®
Gerresheimer Autoinjector
Single–use cartridge–based autoinjector for subcutaneous self–administration. Promoted worldwide by Midas Pharma & Gerresheimer.
Gx Inbeneo® receives Red Dot Award
The Red Dot is an award for high-quality design and a highly valued seal of quality. It is awarded by an international jury only to products that are characterized by an exceptional design.
Gx Inbeneo® – Innovative Features
-
Pre-pressurized system
- Start of injection without spring release mechanism ensures delivery of the drug by minimizing any risk of failure caused by breakage of mechnism
- Reduced protein aggregation due to reduced air bubbles in pressurized solutions
-
Double ended needle
- Effective injection for drugs of low to very high viscosity
- Shortened injection time
- Dry needle system during storage prevents needle clogging
Gx Inbeneo® Capabilities
Platform technology designed to fit drug formulations with different characteristics
- Designed for formulations
of low to very high viscosity - Single-use autoinjector
for subcutaneous self-administration - ISO cartridge based (1.5 or 3.0 mL fill volume)
- 5 ml cartridge concept available
- Adaption for i.m. injections possible
Patient Centric Design
Easy to use autoinjector
- Concealed needle before and after injection
- Automatic needle stick prevention
- Push-on-skin-activation (no separate
spring release mechanism) - Visual and audible end of dose indication:
- End of dose click
- Additional second visual indicator on top of
device to track real time injection process
Benefits Gx Inbeneo® Platform Concept
Tailor the Gx Inbeneo autoinjector to the needs of your drug formulation.
- Designed for biologic drugs and formulations of low to very high viscosity
-
Prevention of needle clogging
- By dry needle system
-
Reduced risk of aggregation
- By using cartridges with baked-on siliconization
-
Customizable
- Patient needle size (25, 27, 29 G)
- ISO cartridge (with 1.5 or 3.0 mL fill volume)
- Spring force (between 30 and 90 N)
- Reduced time-to-market
- Quick and easy tailoring to specific drug formulations from a full-service partner
Product Flyer
Please find the key benefits of the innovative Gx Inbeneo autoinjector summarized in our product flyer.
Gx Inbeneo® Platform Simulator
Find the best suitable configuration for your formulation with our Gx Inbeneo Platform Simulator.
Read the latest Publications on the Gx Inbeneo®
Discover how the Gx Inbeneo autoinjector was purpose-designed to provide an effective, easy-to-use solution for the subcunateous self-administration of sensitive biopharmaceuticals.
-
PDF, 4.0 MBDownloadUser-Centric Device DevelopmentGerresheimer, June 2026
-
PDF, 2.5 MBDownloadGreater formulation freedom with a novel autoinjector platformONdrugDELIVERY, May 2025
-
PDF, 2.6 MBDownloadTesting proves design concept of novel autoinjector platformONdrugDELIVERY, October 2024
-
PDF, 2.6 MBDownloadThe Autoinjector ConceptDrug Delivery and Translational Research, May 2024
-
PDF, 2.4 MBDownloadGx Inbeneo® Platform SimulatorONdrugDELIVERY, January 2024
-
PDF, 2.4 MBDownloadGx Inbeneo® AutoinjectorONdrugDELIVERY, October 2023
Your Contact
Dr. Matthias Bauch
Biopharma Business Development
Global Vice President